Blood Pressure Challenge Reduces Hematomas in Gender-Affirming Mastectomy A Retrospective Chart Review of 92 Consecutive Patients

被引:1
|
作者
Slate-Romano, John J. [1 ,3 ]
Zeyl, Victoria G. [1 ]
Beqiri, Dardan [2 ]
Sobti, Nikhil [2 ]
Rao, Vinay [2 ]
Kwan, Daniel [2 ]
机构
[1] Brown Univ, Warren Alpert Med Sch, Sch Med, Providence, RI USA
[2] Rhode Isl Hosp, Warren Alpert Sch Med, Dept Plast Surg, Providence, RI USA
[3] Brown Univ, Warren Alpert Med Sch, 222 Richmond St, Providence, RI 02903 USA
关键词
hematomas; gender-affirming mastectomy; breast reconstruction; double incision mastectomy; postoperative complications; TO-MALE TRANSSEXUALS; WALL CONTOURING SURGERY; QUALITY-OF-LIFE; CHEST RECONSTRUCTION; SUBCUTANEOUS MASTECTOMY; HORMONAL-THERAPY; COMPLICATIONS; REASSIGNMENT;
D O I
10.1097/SAP.0000000000003537
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundGender-affirming mastectomy is a common surgery for the treatment of gender incongruence and gender dysphoria and improves quality of life. Hematoma rates for gender-affirming double incision mastectomies are between 2.8% and 8.1%. This study aims to investigate the utility of a blood pressure challenge, whereby the patient's blood pressure is medically increased intraoperatively to reveal bleeding vessels that can be addressed with additional hemostasis before skin closure, to reduce postoperative hematoma.MethodsA retrospective chart review of patients who underwent gender-affirming double incision mastectomies over a 6-year period by a single surgeon was conducted. Surgeries were separated into a blood pressure challenge experimental group and a non-blood pressure challenge control group. Demographics, surgical characteristics, and postoperative complications were compared between the 2 cohorts using Pearson chi(2), Fisher exact, t tests, univariate logistic regression, and multivariable logistical regression. Significance was established at P < 0.05.ResultsA total of 92 patients (184 breasts) were included with 32 patients (64 breasts) in the control group and 60 (120 breasts) in the blood pressure challenge group. In the control group, there were 5 hematomas (7.81%) compared with 1 (0.83%) in the blood pressure challenge group (P = 0.02). On univariate logistical regression analysis, blood pressure challenge was the only variable significantly associated with hematoma (odds ratio, 0.1; 95% confidence interval, 0.01-0.63; P = 0.04). On multivariable logistical regression, after controlling for age, body mass index, smoking status, and mass of excised breast tissue, patients who underwent blood pressure challenge demonstrated lower hematoma rates (odds ratio, 0.08; 95% CI, 0.004-0.59; P = 0.04).ConclusionsUsing an intraoperative blood pressure challenge was associated with reduced hematoma rates. Guidelines for blood pressure challenge goals should be established to standardize care and reduce complications in gender-affirming mastectomies.
引用
收藏
页码:301 / 305
页数:5
相关论文
共 4 条
  • [1] Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review
    Connelly, Paul J.
    Clark, Anna
    Touyz, Rhian M.
    Delles, Christian
    JOURNAL OF HYPERTENSION, 2021, 39 (02) : 223 - 230
  • [2] Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations
    Pamulapati, Saagar
    Conroy, Meghan
    Cortina, Chandler
    Harding, Eric
    Kamaraju, Sailaja
    ARCHIVES OF SEXUAL BEHAVIOR, 2024, 53 (05) : 1969 - 1980
  • [3] Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations
    Saagar Pamulapati
    Meghan Conroy
    Chandler Cortina
    Eric Harding
    Sailaja Kamaraju
    Archives of Sexual Behavior, 2024, 53 : 1969 - 1980
  • [4] A retrospective electronic chart review of blood pressure changes in elderly patients treated with amlodipine or an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker
    Dollar, A
    Brown, C
    Putnam, D
    McLaughlin, T
    Okamoto, L
    Arocho, R
    CLINICAL THERAPEUTICS, 2002, 24 (06) : 930 - 941